Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Unit to Use Thermo Fisher's Fluorescent Dyes to Develop Reagents

NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said synthetic antibody developer AbD Serotec will use its DyLight dyes as part of a collaborative agreement to develop a series of fluorescent reagents.
 
Under the agreement, Serotec, a subsidiary of MorphoSys, will develop and sell the resulting products through its catalog, Thermo said.
 
Thermo said its DyLight products are water soluble and provide high fluorescent intensity in various applications.
 
Serotec has a catalog of more than 10,000 research antibodies, and it develops monoclonal antibodies using its parent company’s HuCal technology.
 
Financial terms of the agreement were not disclosed.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.